ALS Drug Development Webinar Series Part 2: Regulatory Considerations

Join us for the second installment of the NEALS webinar series on ALS drug development moderated by Dr. Jinsy Andrews from Columbia University. This series will include talks on the preclinical development of potential therapies, the regulatory pathway, the science of trials, the clinical trial site level overview, and the importance of patient engagement.

In this webinar, Peter DiRoma will take us through the regulatory process and Holly Fernandez Lynch will discuss how the COVID-19 vaccines were developed and learnings that may apply to other disease areas.